相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A predictive probability design for phase II cancer clinical trials
J. Lack Lee et al.
CLINICAL TRIALS (2008)
Bayesian adaptive design for targeted therapy development in lung cancer - a step toward personalized medicine
Xian Zhou et al.
CLINICAL TRIALS (2008)
Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)
Christopher M. Booth et al.
EUROPEAN JOURNAL OF CANCER (2008)
Novel trial design: A report from the 19th Frontiers Symposium of ACCP
Barbara Ameer
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Bayesians in clinical trials:: Asleep at the switch
Lemuel A. Moye
STATISTICS IN MEDICINE (2008)
Practical Bayesian design and analysis for drug and device clinical trials
Brian P. Hobbs et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2008)
Statistics in the world of medical devices: The contrast with pharmaceuticals
Gregory Campbell
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2008)
A parallel phase I/II clinical trial design for combination therapies
Xuelin Huang et al.
BIOMETRICS (2007)
Bayesian statistics in medicine: A 25 year review
Deborah Ashby
STATISTICS IN MEDICINE (2006)
FDA's critical path initiative: A perspective on contributions of biostatistics
R. T. O'Neill
BIOMETRICAL JOURNAL (2006)
Adaptive seamless phase II/III designs - Background, operational aspects, and examples
Jeff Maca et al.
DRUG INFORMATION JOURNAL (2006)
Adaptive dose-response studies
Brenda Gaydos et al.
DRUG INFORMATION JOURNAL (2006)
The Relationship Between the Power Prior and Hierarchical Models
Ming-Hui Chen et al.
BAYESIAN ANALYSIS (2006)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
AU Buzdar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Relationship between Bayesian and frequentist sample size determination
LYT Inoue et al.
AMERICAN STATISTICIAN (2005)
Bayesian predictions of final outcomes: regulatory approval of a spinal implant
B Lipscomb et al.
CLINICAL TRIALS (2005)
Introduction to Bayesian methods II: fundamental concepts
TA Louis
CLINICAL TRIALS (2005)
Introduction to Bayesian methods I: measuring the strength of evidence
SN Goodman
CLINICAL TRIALS (2005)
Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis
DA Berry
CLINICAL TRIALS (2005)
Bayesian survival analysis with nonproportional hazards: Metanalysis of combination pravastatin-aspirin
SM Berry et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Bayesian statistics and the efficiency and ethics of clinical trials
DA Berry
STATISTICAL SCIENCE (2004)
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease - Randomized and observational comparisons of secondary prevention trials and their meta-analyses
CH Hennekens et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia
FJ Giles et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
DJ Lunn et al.
STATISTICS AND COMPUTING (2000)
分享论文
